Delivery Order SPE2DB22D2206-SPE2DB25FGU95
Award Date
5/1/25
Potential Completion Date
5/22/25
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,249.20 firm fixed price contract is for the delivery of the medication Zoladex 3.6 mg implant syringes, with a completion date of November 5, 2024. Amerisourcebergen provides a broad range of pharmaceutical and medical supplies to federal agencies through various Indefinite Delivery Contracts (IDCs), including a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $7,018.24 Firm Fixed Price Delivery Order is for the supply of the medication Zoladex 10.8 mg Implant Syringes. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of the drug Zoladex 10.8 MG Implant Syrinses. The contract is valued at $1,754.58 and has an ultimate completion date of June 21, 2024. It is a Firm Fixed Price contract, meaning the price will not change regardless of the contractor's costs. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This federal contract award, valued at $8,772.80, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Zoladex 10.8 mg implant syringes, a specialty pharmaceutical product. The award is not designated as a set-aside contract. It is a firm fixed-price delivery order with a completion date of May 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,735.50, is a Firm Fixed Price Delivery Order to provide ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has a completion date of March 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,263.74 fixed-price delivery order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has a completion date of November 25, 2024 and was awarded on November 1, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $10,527.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565687987 ZOLADEX 10.8 MG IMPLANT SYRNS, a pharmaceutical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This IDC enables DLA to efficiently...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,610,200 units of the pharmaceutical product ZOLADEX 10.8 MG IMPLANT SYRNS. The contract has a completion date of February 29, 2024 and a potential value of $8,772.80. No set-aside designation was used for this award. AmerisourceBergen Drug Corp serves as a prime contractor to DLA, providing a wide range of...
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB25FM3Q6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,314.00 Firm Fixed Price Delivery Order contract is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $2,379.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,565,607,277 ZOLADEX 10.8 MG IMPLANT SYRNS, a pharmaceutical product. The contract has a firm fixed price and a period of performance through September 17, 2024. AmerisourceBergen, as a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded...